Sulforaphane Effectively Inhibits HBV by Altering Treg/Th17 Immune Balance and the MIF-Macrophages Polarizing Axis In Vitro and In Vivo

An immunocompetent hepatitis B virus (HBV) CBA/CaJ mouse model and a co-culture model were used to explore the effect of sulforaphane (SFN) on HBV and whether SFN altered the immune balance after HBV infection.